Planar Chiral Cp*Ru Complexes
Organometallics, Vol. 16, No. 18, 1997 3957
(5S,1R)-[(1-H yd r oxy-η2-5-isop r op en e-2-m et h yl-η4-cy-
cloh exa -1,3-d ien e)(η5-p en t a m et h ylcyclop en t a d ien yl)-
r u th en iu m (II)] Tr iflu or om eth a n esu lfon a te (8‚CF 3SO3).
Prepared analogous to 7 from 250 mg (0.43 mmol) of 1, 0.8
mmol (70 µL) of CF3SO3H, and 0.86 mmol (0.190 mL) of 5.
Yield: 0.322 g (70%). Fp: 145 °C dec. [R]54625 ) -349 (acetone,
c ) 8.65 × 10-3 g‚cm-3). 1H NMR (500 MHz, CD2Cl2): 1.72
(s, Cp*, 15H), 1.99 (d, H1, J ) 0.5 Hz, 3H), 4.57 (d, H3, J )
6.6 Hz, 1H), 2.44 (ddd, H4, J ) 6.5, 5.3, 1.2 Hz, 1H), 3.34 (ddd,
H5, J ) 5, 5, 1.5 Hz, 1H), 1.24 (ddd, H6, J ) 15.4, 4.9, 0.7 Hz,
1H), 1.31 (ddd, H6′, J ) 15.5, 1.4, 1.4 Hz, 1H), 2.03 (s, H10,
3H), 2.75 (d, H9syn, J ) 1 Hz, 1H), 3.19 (d, H9anti, J ) 1.5 Hz,
1H). 13C NMR (125.6 MHz, CD2Cl2): 10.2, 93.7 (Cp*), 14.4
(C1), 76.4 (C2), 77.8 (C3), 33.9 (C4), 34.3 (C5), 23.3 (C6), 145.9
(C7), 60.3 (C8), 23.2 (C10), 49.3 (C9), 120.9 (q, CF3SO3-, J CF
) 320 Hz). IR (KBr, ν, cm-1): 3275 (m), 2917 (m), 1551 (s),
1484 (m), 1385 (m), 1289 (s), 1258 (s), 1227 (s), 1206 (s), 1157
CDCl3): 1.82 (s, Cp*, 15H), 5.30 (d, H3, J ) 5.8 Hz, 1H), 5.13
(dbr, H4, J ) 5.8 Hz, 1H), 6.14 (sbr, H6, 1H), 1.99 (s, H1, 3H),
2.50 (sept, H8, J ) 7.0 Hz, 1H), 1.19 (d, H9, H10, J ) 7.0 Hz,
3H), 1.26 (d, J ) 7.0 Hz, 3H), 9.36 (sbr, OH, 1H). 13C NMR
(125.6 MHz, CDCl3): 9.9, 93.7 (Cp*), 13.2 (C1), 110.1 (C2), 86.7,
81.0, 75.7 (C3, C4, C6), 88.8 (C5), 129.6 (C7), 30.8 (C8), 22.5,
22.8 (C9, C10), 120.9 (q, CF3SO3-, J CF ) 320 Hz). IR (KBr, ν,
cm-1): 3096 (m), 2973 (w), 2920 (w), 1536 (w), 1476 (m), 1453
(w), 1406 (m), 1387 (m), 1327 (m), 1298 (s), 1237 (s), 1221 (s),
1165 (s), 1030 (s), 638 (s). MS (FAB): m/z (Irel) +VE 387 (100,
M+ - CF3SO3-), 371 (8, M+ - CH4 - CF3SO3-), 357 (2, M+
-
C2H5 - CF3SO3-), 343 (1, M+ - i-Pr - CF3SO3-), 233 (3,
(Cp*Ru)+ - 4H); -VE 149 (100, CF3SO3-). Anal. Calcd for
[C21H29F3O4RuS]: C, 47.10; H, 5.46. Found: C, 46.53; H, 5.45.
(1 S )-[(η6 -1 -(S )-C a m p h o r s u l fo n y l -5 -i s o p r o p y l -2 -
m et h yl p h en ola t e)(η5-p en t a m et h ylcyclop en t a d ien yl)-
r u th en iu m (II)] Ch lor id e (15a ‚Cl). When an ether solution
of 0.043 g (0.17 mmol) of (1S)-(+)-camphor-10-sulfonyl chloride
was added to 0.066 g (0.17 mmol) of 13a dissolved in ether,
the product separated as a white solid, which was washed two
times with ether and dried. Yield: 0.104 g (96%). 1H NMR
(500 MHz, CDCl3): 1.88 (s, Cp*, 15H), 6.59 (dbr, H3, J ) 5.8
Hz, 1H), 6.06 (dbr, H4, J ) 5.8 Hz, 1H), 6.18 (sbr, H6, 1H), 2.24
(s, H1, 3H), 2.68 (sept, H8, J ) 6.9 Hz, 1H), 1.228 (d, H9, H10,
J ) 6.9 Hz, 3H), 1.230 (d, J ) 6.9 Hz, 3H), 3.80 (d, H11, H11′,
J ) 14.9 Hz, 1H), 3.36 (d, J ) 14.9 Hz, 1H), 1.88 (m, H14,
H14′, 1H), 2.37 (ddd, J ) 18.6, 4.0, 4.0 Hz, 1H), 2.12 (dd, H15,
J ) 4.4, 4.4 Hz, 1H), 1.42 (ddd, H16, H16′, J ) 13.0, 9.4, 4.0
Hz, 1H), 2.03 (m, 1H), 1.70 (m, H17, H17′, 1H), 2.29 (ddd, J )
15.0, 12.0, 4.0 Hz, 1H), 0.89 (s, H19, H20, 3H), 1.07 (s, 3H).
13C NMR (125.6 MHz, CDCl3): 10.2, 96.1 (Cp*), 13.9 (C1),
110.6 (C2), 86.5 (C3), 89.5 (C4), 95.2 (C5), 80.5 (C6), 119.4 (C7),
30.3 (C8), 22.4, 22.9 (C9, C10), 50.0 (C11), 58.2 (C12), 213.4
(C13), 42.4 (C14), 42.8 (C15), 26.7 (C16), 25.7 (C17), 48.2 (C18),
19.4, 19.6 (C19, C20).
(s), 1099 (m), 1033 (s), 978 (m), 637 (s). MS (FAB): m/z (Irel
)
+VE 387 (100, M+ - CF3SO3-), 385 (75, M+ - H2 - CF3SO3-),
371 (6, M+ - CH4 - CF3SO3-), 233 (3, (Cp*Ru)+ - 4H); -VE
149 (100, CF3SO3-). Anal. Calcd for [C21H29F3O4RuS]: C,
47.10; H, 5.46. Found: C, 47.19; H, 5.55.
(5S,2S)-(η2-5-Isop r op en -2-m et h yl-η3-cycloh ex-2-en -1-
on e-4-yl)(η5-p en t a m et h ylcyclop en t a d ien yl)r u t h en iu m -
(II) (9). Prepared by deprotonation of 8 (200 mg, 0.37 mmol)
with Et3N in acetone. Yield after extraction into hexane was
0.130 g (90%) as orange crystals. Fp: 163 °C. [R]54625 ) +146
(acetone, c ) 5.95 × 10-3 g‚cm-3). 1H NMR (500 MHz, CD2-
Cl2): 1.66 (s, Cp*, 15H), 1.41 (s, H1, 3H), 3.89 (d, H3, J ) 5.8
Hz, 1H), 2.65 (ddd, H4, J ) 6.7, 5.8, 1.2 Hz, 1H), 3.05 (ddd,
H5, J ) 6.5, 5.5, 2.1 Hz, 1H), 0.97 (ddd, H6, J ) 16.2, 2.1, 1.2
Hz, 1H), 1.07 (dd, H6′, J ) 16.2, 5.5 Hz, 1H), 1.88 (s, H9, 3H),
1.47 (d, H10syn, J ) 1.2 Hz, 1H, Hg), 2.05 (d, H10anti, J ) 1.2
Hz, 1H, Hg′). 13C NMR (125.6 MHz, CD2Cl2): 10.4, 90.3 (Cp*),
18.3 (C1), 43.9 (C2), 82.9 (C3), 24.9 (C4), 34.6 (C5), 34.8 (C6),
201.8 (C7), 58.5 (C8), 27.3 (C9), 43.7 (C10). IR (KBr, ν, cm-1):
2947 (w), 2888 (m), 1625 (s), 1377 (m), 1349 (m), 1311 (m),
(1R ,1S )-[(η6 -(S )-C a m p h o r s u lfo n y l-5-i s o p r o p y l-2-
m et h yl p h en ola t e)(η5-p en t a m et h ylcyclop en t a d ien yl)-
r u th en iu m (II)] Tr iflu or om eth a n esu lfon a te (15b). To 0.2
g (0.34 mmol) of [Cp*RuOMe]2 in 5 mL of acetone was added
60 µL (0.69 mmol) of CF3SO3H and subsequently 107 mL (0.69
mmol) of 5-isopropyl-2-methylphenol (carvacrol). The resulting
phenol complex was precipitated by addition of 50 mL of ether,
redissolved in acetone, and precipitated to give 0.18 g (50%)
as the triflate salt. After drying under high vacuum, the
complex was treated in ether with an equimolar amount of
n-BuLi to generate the neutral oxocyclohexadienyl complex
13b. To the mixture containing 13, LiCl, and CF3SO3Li in
ether was added an equimolar amount of (S)-(+)-camphor-10-
sulfonyl chloride. The resulting solid was separated, washed
with ether, and dried under high vacuum. It was freed from
1021 (m), 704 (w). MS (70 eV, EI): m/z (Irel) 385 (100, M+
H), 371 (78, M+ - CH3), 357 (24, M+ - C2H5), 343 (48, M+
-
-
i-Pr), 232 (28, (Cp*Ru)+ - 5H). Anal. Calcd for [C20H28ORu]:
C, 62.31; H, 7.32. Found: C, 62.24; H, 7.57.
(5R)-(η5-5-Isop r op yl-2-m eth yl-1-oxocycloh exa d ien yl)-
(η5-p en ta m eth ylcyclop en ta d ien yl)r u th en iu m (II) (13). (a)
To 0.37 g (1.27 mmol) of [Cp*RuOMe]2 dissolved in 10 mL of
benzene was added 0.4 mL (2.54 mmol) of (R)-(-)-dihydrocar-
vone. After 4 days at 30 °C, the solvent was removed in vacuo
and excess dihydrocarvone was extracted with hexane. The
residual orange brown solid was dissolved in Et2O, and the
solution was filtered over Celite. On concentration of the
solution, 0.23 g (47%) of product precipitated as a colorless
25
-
solid. Fp: 177 °C. [R]546 ) +1.6 (acetone, c ) 5.0 × 10-3
LiCl by dissolving in CHCl3, where only the CF3SO3 salt is
g‚cm-3). 1H NMR (500 MHz, CDCl3): 1.74 (s, Cp*, 15H), 1.77
(sbr, H1, 3H), 5.00 (d, H3, J ) 5.5 Hz, 1H), 4.72 (dd, H4, J )
5.5, 1.0 Hz, 1H), 4.87 (sbr, H6, 1H), 2.25 (sept, H8, J ) 6.9 Hz,
1H), 1.12 (d, H9, H10, J ) 6.9 Hz, 3H), 1.12 (d, J ) 6.9 Hz,
3H). 13C NMR (125.6 MHz, CDCl3): 10.1, 89.6 (Cp*), 14.8 (C1),
109.6 (C2), 87.1, 76.6, 75.4 (C3, C4, C6), 87.5 (C5), 149.1 (C7),
31.0 (C8), 22.3, 23.2 (C9, C10). IR (KBr, ν, cm-1): 3034 (w),
2955 (m), 2904 (m), 1555 (s), 1500 (m), 1477 (m), 1379 (m),
soluble, filtering off the solid, and evaporating the solvent. 1H
NMR (500 MHz, CDCl3): 1.86, 1.87 (s, Cp*, 15H), 6.05, 6.07
(dbr, H3, J ) 6.1 Hz, 1H), 5.83, 5.85 (dbr, H4, J ) 6.0 Hz, 1H),
6.16, 6.16 (sbr, H6, 1H), 2.20, 2.22 (s, H1, 3H), 2.675, 2.680
(sept, H8, J ) 7.0 Hz, 1H), 1.236, 1.256 (d, H9, H10, J ) 7.0
Hz, 3H), 1.250, 1.256 (d, J ) 7.0 Hz, 3H), 3.79, 3.81 (d, H11,
H11′, J ) 15.0 Hz, 1H), 3.30, 3.40 (d, J ) 15.0 Hz, 1H), 1.4-
2.5 (aliphatic protons, H14, H14′, H15, H16, H16′, H17, H17′,
7H), 0.89, 0.92 (s, H19, H20, 3H), 1.070, 1.085 (s, 3H). 13C
NMR (125.6 MHz, CDCl3): 9.92, 9.94, 96.33, 96.35 (Cp*),
13.90, 13.95 (C1), 111.25, 111.32 (C2), 85.88, 86.04 (C3), 88.82,
88.82 (C4), 95.39, 95.53 (C5), 80.40, 80.89 (C6), 119.49, 119.96
(C7), 30.31, 30.38 (C8), 22.41, 22.46, 22.76, 22.81 (C9, C10),
49.57, 50.05 (C11), 58.04, 58.25 (C12), 213.49, 214.00 (C13),
42.47, 42.47 (C14), 42.68, 42.94 (C15), 26.80, 26.86 (C16),
25.30, 25.84 (C17), 48.36, 48.49 (C18), 19.29, 19.31, 19.49,
19.53 (C19, C20).
1363 (m), 702 (m). MS (70 eV, EI): m/z (Irel) 385 (63, M+
H), 371 (100, M+ - CH3), 358 (7, M+ - C2H4), 343 (8, M+
-
-
i-Pr), 233 (14, (Cp*Ru)+ - 4H). Anal. Calcd for [C20H28ORu]:
C, 62.31; H, 7.32. Found: C, 62.00; H, 7.43. (b) As performed
above using 11 instead of 4, yield 47%.
(1S)-[(η6-5-Isop r op yl-2-m eth ylp h en ol)(η5-p en ta m eth yl-
cyclop en t a d ien yl)r u t h en iu m (II)] Tr iflu or om et h a n e-
su lfon a te ((S)-14‚CF 3SO3). 13a (0.2 g, 0.52 mmol) was
treated in acetone with 50 µL (0.52 mmol) of CF3SO3H. The
reddish brown acetone solution was passed over silylated silica,
eluted with acetone, concentrated, and cooled to -78 °C to
(1R,1S)-[(η6-1-Acetyl-5-isop r op yl-2-m eth yl p h en ola te)-
(η5-p en ta m eth ylcyclop en ta d ien yl)r u th en iu m (II)] Tr if-
lu or om eth a n esu lfon a te (16). To 895 mg (1.67 mmol) of 14b
(prepared by reaction of 450 mg (0.84 mmol) of [Cp*RuOMe]2
25
separate 0.264 g (95%) of brown crystals. Fp: 190 °C. [R]546
) +83 (acetone, c ) 1.20 × 10-3 g‚cm-3). 1H NMR (500 MHz,